1. Home
  2. BTTC vs NVNO Comparison

BTTC vs NVNO Comparison

Compare BTTC & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTTC

Black Titan Corporation Ordinary Shares

HOLD

Current Price

$0.93

Market Cap

8.0M

Sector

Health Care

ML Signal

HOLD

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

N/A

Current Price

$10.79

Market Cap

6.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BTTC
NVNO
Founded
1990
1987
Country
Malaysia
United States
Employees
N/A
33
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0M
6.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BTTC
NVNO
Price
$0.93
$10.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
115.9K
12.9K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$140.00
P/E Ratio
$2.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.30
52 Week High
$11.22
$13.44

Technical Indicators

Market Signals
Indicator
BTTC
NVNO
Relative Strength Index (RSI) 55.28 50.23
Support Level $0.68 $9.93
Resistance Level $1.23 $11.15
Average True Range (ATR) 0.06 0.73
MACD 0.03 -0.05
Stochastic Oscillator 69.70 25.98

Price Performance

Historical Comparison
BTTC
NVNO

About BTTC Black Titan Corporation Ordinary Shares

Black Titan Corp provides human resource and payroll consulting, software implementation, and training solutions using PeopleSoft platforms. The company's revenue is mainly derived from the provision of HCM solutions, followed by the provision of IT staff augmentation, outsourcing and consulting services.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: